Boston Tech
Edge of Elsewhere Gives Somerville a Save Button for Leaving the House
Edge of Elsewhere opens in Somerville with interactive art, puzzle chapters, and saved progress. A promising experiment in games you physically walk into.
Boston Tech
Edge of Elsewhere opens in Somerville with interactive art, puzzle chapters, and saved progress. A promising experiment in games you physically walk into.
Boston Tech
Cambridge’s General Flash disclosed $128 million for critical-metal production. Its next test is turning a promising pilot into dependable factory output.
Boston Tech
Boston’s Asimov and Emergent BioSolutions are developing research cell banks for two Ebola antibody candidates, an early step toward making material for study.
Boston Tech
BioBuilder is piloting Transfyr’s AI video coach at its Allston lab to see whether more students can get useful feedback while practicing hands-on biotech skills.
Boston Tech
MIT researchers designed synthetic emissions scenarios that helped a climate emulator handle unfamiliar policy changes. A full-scale test still lies ahead.
Boston Tech
Billerica-based Fabri combines 3D-printed patterns and foundry software to speed metal casting, with real customers and bigger production ambitions for 2027.
Boston Tech
Bedford biotech Delix raised $100 million to advance zalsupindole into Phase II depression testing, pursuing psychedelic-inspired medicine without the trip.
Boston Tech
Harvard’s FIND platform uses DNA nanoswitches to screen for molecules that change protein interactions, advancing Boston’s drug-discovery toolbox.
Boston Tech
Boston-based Lazarus AI announced $43 million to expand enterprise AI for documents, cybersecurity, and legacy software, with customer control at its core.
Boston Tech
KNAPP announces a Somerville robotics and AI lab, targeting 30–35 staff by early 2027 to turn warehouse research into reliable industrial products.
Boston Tech
Baystate launched an Oracle Health EHR as Mercy Hospital joined its Massachusetts system November 1. Unified records now face the practical test of care.
Boston Tech
DropGenie’s $5 million Seed+ round backs miniature gene-editing workflows in Cambridge and Montréal, with promising lab evidence and a 2027 rollout ahead.